CureVac(CVAC) - 2025 Q1 - Quarterly Report

CureVac N.V. Unaudited Interim Condensed Consolidated Financial Statements As of March 31, 2025 and December 31, 2024 and for the three months ended March 31, 2025 and 2024 CureVac N.V. Unaudited Interim Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) | | | Three months ended March 31, | | | --- | --- | --- | --- | | (in thousands of EUR, except per share amounts) | Note | 2024 | 2025 | | Revenue | 3.1 | 12,373 | 893 | | Cost of sales | 3.2 | (41,690) | (875) | | Sellin ...